The findings echo early results from the decade-long Epicure 2 study, published last month, which also showed improved survival rates for babies born at 24 and 25 weeks, but not for those born earlier.
The remarks echo those by DoubleLine Capital chief Jeffrey Gundlach, who told Reuters he has spent the last month buying 10-year Treasuries, and that he thinks stocks are overbought in the short-term.